GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Resectable MAGE-A3 Positive Non-Small Cell Lung Cancer
"http://www.immunotherapyforcancer.info provides information on the cancer immunotherapeutic
approach in an easy-to-understand format" "http://www.ascitrials.com gives practical
information on the MAGRIT clinical study"
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Disease-free survival
At predefined time points
No
GSK Clinical Trials
Study Director
GlaxoSmithKline
United States: Food and Drug Administration
109493
NCT00480025
October 2007
September 2022
Name | Location |
---|---|
GSK Investigational Site | Phoenix, Arizona 85013 - 4496 |
GSK Investigational Site | Bakersfield, California 93309 |
GSK Investigational Site | Gainesville, Florida 32610 |
GSK Investigational Site | Indianapolis, Indiana 46260 |
GSK Investigational Site | Lexington, Kentucky 40536-0098 |
GSK Investigational Site | Springfield, Massachusetts 01107 |
GSK Investigational Site | Duluth, Minnesota 55805 |
GSK Investigational Site | St. Louis, Missouri 63141 |
GSK Investigational Site | Raleigh, North Carolina 27609 |
GSK Investigational Site | Akron, Ohio 44304 |
GSK Investigational Site | Fort Worth, Texas 76104 |
GSK Investigational Site | Green Bay, Wisconsin 54301 |
GSK Investigational Site | Savannah, Georgia 31405 |
GSK Investigational Site | Park Ridge, Illinois 60068 |
GSK Investigational Site | Bettendorf, Iowa 52722 |
GSK Investigational Site | Baltimore, Maryland 21201 |
GSK Investigational Site | Royal Oak, Michigan 48073 |
GSK Investigational Site | Hooksett, New Hampshire 03106 |
GSK Investigational Site | Pittsburgh, Pennsylvania 15213 |
GSK Investigational Site | Columbia, South Carolina 29210 |
GSK Investigational Site | Germantown, Tennessee 38138 |
GSK Investigational Site | Salem, Virginia 24153 |
GSK Investigational Site | New York, New York 10021 |
GSK Investigational Site | Birmingham, Alabama 35209 |
GSK Investigational Site | Aurora, Colorado 80012 |
GSK Investigational Site | Washington, District of Columbia 20307-5001 |
GSK Investigational Site | Coeur d'Alene, Idaho 83814 |
GSK Investigational Site | Omaha, Nebraska 68131 |
GSK Investigational Site | Edison, New Jersey 08837 |
GSK Investigational Site | Oregon City, Oregon 97045 |
GSK Investigational Site | Cranston, Rhode Island 02920 |
GSK Investigational Site | Seattle, Washington 98133 |
GSK Investigational Site | Newark, Delaware 19713 |